Integra LifeSciences | IART - Selling And Administration Expenses

Integra Lifesciences reported $143.78M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Selling And Administration Expenses Change
Abbott ABT:US USD 2.83B 98M
Atricure ATRC:US USD 55.5M 1.77M
Baxter International BAX:US USD 986M 204M
Becton, Dickinson and BDX:US USD 1.19B 5M
Boston Scientific BSX:US USD 1.16B 31M
Conmed CNMD:US USD 116.98M 14.79M
Cooper Companies COO:US USD 299.1M 56.9M
Dexcom DXCM:US USD 297.8M 63.2M
Edwards Lifesciences EW:US USD 411M 33.7M
Globus Medical GMED:US USD 118.07M 11.5M
Hologic HOLX:US USD 272M 15.5M
Insulet PODD:US USD 144.3M 3.9M
Integra Lifesciences IART:US USD 143.78M 832K
Intuitive Surgical ISRG:US USD 494.3M 59.6M
Johnson & Johnson JNJ:US USD 6.51B 423M
Medtronic MDT:US USD 2.58B 129M
Merit Medical Systems MMSI:US USD 83.24M 6.54M
Nuvasive NUVA:US USD 159.11M 5.11M
Orthofix International OFIX:US USD 84.79M 10.01M
Smith & Nephew PLC SN/:LN 1.21B 64M
Stryker SYK:US USD 1.59B 109M
Tandem Diabetes Care TNDM:US USD 97.69M 13.59M
Teleflex TFX:US USD 233.38M 23.76M
Zimmer Biomet Holdings Inc ZBH:US USD 727.1M 72.2M